Money Compass

Money Compass

Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025. Encouraging clinical data showed that patients receiving 60 mg QD...

Read more
Page 2366 of 2775 1 2,365 2,366 2,367 2,775

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.